PR Newswire POMPANO BEACH, Fla., April 8, 2025 POMPANO BEACH, Fla., April 8, 2025 /PRNewswire/ -- A newly published study in the American Society of Nephrology's Kidney360 journal highlights a valuable therapy in the management of patients ...
PR Newswire SPRING HOUSE, Pa., April 8, 2025 New compelling results demonstrate 18 months of both sustained reduction in immunoglobulin G antibodies and sustained improvement in gMG symptoms in pivotal Vivacity-MG3 study and open-label ...
PR Newswire BOSTON, April 3, 2025 New Research Highlights the Power of Whole Foods Plant-Based Diets in Burnout Reduction and COVID-19 Recovery BOSTON, April 3, 2025 /PRNewswire/ -- The Virsa Foundation, through its JIVINITI Research ...
PR Newswire KANAZAWA, Japan, April 3, 2025 KANAZAWA, Japan, April 3, 2025 /PRNewswire/ -- Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, demonstrates a novel approach for nanoscopic profiling of small extracellular vesicles ...
Modern Aminos: Pioneering Aminos Research in Scientific Innovation Modern Aminos leads the way in scientific exploration. In our research lab, Aminos Research takes center stage as we analyze compounds with precision. Our focus is on ...
PR Newswire SINGAPORE and PRINCETON, N.J., March 27, 2025 SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., March 27, 2025 /PRNewswire/ -- ...
PR Newswire NEW YORK, March 25, 2025 NEW YORK, March 25, 2025 /PRNewswire/ -- Today, The Michael J. Fox Foundation for Parkinson's Research (MJFF) announces the selection of five high priority targets through its Targets to Therapies ...
PR Newswire WASHINGTON, March 14, 2025 WASHINGTON, March 14, 2025 /PRNewswire/ -- The Human Animal Bond Research Institute (HABRI) and Pet Partners today announced the publication of an important study showing significant reductions in child ...
PR Newswire HERZLIYA, Israel and WILMINGTON, Del., March 13, 2025 HERZLIYA, Israel and WILMINGTON, Del., March 13, 2025 /PRNewswire/ -- Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the ...
PR Newswire SPRING HOUSE, Pa., March 10, 2025 Topline results also show investigational targeted oral peptide icotrokinra achieved clinical remission rates up to 30.2% at Week 12 and a favorable safety profile in Phase 2b ANTHEM-UC study ...
Gut–brain interplay and fermentable carbs, not gluten, often explain symptoms in people labelled gluten-sensitive.
A large MRI study reveals men have more ACL, meniscal, and MCL knee injuries than women, with patterns varying by age, aiding tailored risk assessment.
Even subtle hearing loss to faster brain decline and higher dementia risk, particularly for people with the APOE ε4 Alzheimer’s-related gene.
One in two people in the U.S. lives with a neurological condition, highlighting a growing public health crisis and the urgent need for better prevention and care.
Researchers identified a brain circuit driving compulsive behaviors, offering new insights into Obsessive-Compulsive Disorder (OCD) and addiction.